Venture capital 3 articles

Venture capital is private equity financing supplied to young or growth-stage companies in exchange for an ownership stake, usually through staged investment rounds. In biotechnology, venture funding often supports long periods of research, preclinical work, clinical development and company building before products generate revenue. The term is distinct from public-market financing because investors negotiate private securities, governance rights and valuation terms, often syndicating risk across several specialized life-science funds.

AI in Biology

September 20, 2026, 1:33 PM · 4 mins read

Lōkahi Therapeutics extends partnership with University of Alabama for hands-on biotech asset scouting

Lōkahi Therapeutics is strengthening its collaboration with The University of Alabama’s Culverhouse College of Business, giving students direct experience in evaluating real biopharma assets through the ai² Pipeline division.

Biotech Companies & Pipelines

September 19, 2026, 2:30 PM · 4 mins read

Holtec Nuclear delays IPO as Nscale eyes multibillion dollar debut

Holtec Nuclear abruptly postponed its $825 million IPO while Nscale filed for a potential $2 billion offering and Electra Therapeutics suffered a rare biotech IPO drop.

Biotechnology News & Analysis

September 19, 2026, 11:27 AM · 4 mins read

North Carolina biotech bets on proof before scale in a fragmented funding surge

North Carolina’s life sciences sector is taking a measured approach to growth, favoring smaller, risk-managed deals and targeted expansions, while a few major players make billion-dollar commitments.